[Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]. FE [Internet]. 2016 Jun. 28 [cited 2025 Oct. 29];17(2):67-80. Available from: https://journals.seedstm.com/index.php/FE/article/view/1251